Unknown

Dataset Information

0

Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.


ABSTRACT: Dysadherin, a cancer-associated membrane glycoprotein, down-regulates E-cadherin and promotes cancer metastasis. This study examined the role of dysadherin in breast cancer progression. Expression of dysadherin was found to be highest in breast cancer cell lines and tumors that lacked the estrogen receptor (ER). Knockdown of dysadherin caused increased association of E-cadherin with the actin cytoskeleton in breast cancer cell lines that expressed E-cadherin. However, knockdown of dysadherin could still suppress cell invasiveness in cells that had no functional E-cadherin, suggesting the existence of a novel mechanism of action. Global gene expression analysis identified chemokine (C-C motif) ligand 2 (CCL2) as the transcript most affected by dysadherin knockdown in MDA-MB-231 cells, and dysadherin was shown to regulate CCL2 expression in part through activation of the nuclear factor-kappaB pathway. The ability of dysadherin to promote tumor cell invasion in vitro was dependent on the establishment of a CCL2 autocrine loop, and CCL2 secreted by dysadherin-positive tumor cells also promoted endothelial cell migration in a paracrine fashion. Finally, experimental suppression of CCL2 in MDA-MB-231 cells reduced their ability to metastasize in vivo. This study shows that dysadherin has prometastatic effects that are independent of E-cadherin expression and that CCL2 could play an important role in mediating the prometastatic effect of dysadherin in ER-negative breast cancer.

SUBMITTER: Nam JS 

PROVIDER: S-EPMC1557381 | biostudies-literature | 2006 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.

Nam Jeong-Seok JS   Kang Mi-Jin MJ   Suchar Adam M AM   Shimamura Takeshi T   Kohn Ethan A EA   Michalowska Aleksandra M AM   Jordan V Craig VC   Hirohashi Setsuo S   Wakefield Lalage M LM  

Cancer research 20060701 14


Dysadherin, a cancer-associated membrane glycoprotein, down-regulates E-cadherin and promotes cancer metastasis. This study examined the role of dysadherin in breast cancer progression. Expression of dysadherin was found to be highest in breast cancer cell lines and tumors that lacked the estrogen receptor (ER). Knockdown of dysadherin caused increased association of E-cadherin with the actin cytoskeleton in breast cancer cell lines that expressed E-cadherin. However, knockdown of dysadherin cou  ...[more]

Similar Datasets

| S-EPMC8715604 | biostudies-literature
| S-EPMC3062081 | biostudies-literature
| S-EPMC5379033 | biostudies-literature
2013-11-07 | E-GEOD-52162 | biostudies-arrayexpress
| S-EPMC6874098 | biostudies-literature
| S-EPMC7659385 | biostudies-literature
2013-11-07 | GSE52162 | GEO
| S-EPMC3320958 | biostudies-literature
| S-EPMC4573552 | biostudies-literature
| S-EPMC9175512 | biostudies-literature